Mather Group LLC. Has $2.69 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Mather Group LLC. raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,319 shares of the healthcare conglomerate’s stock after acquiring an additional 198 shares during the quarter. Mather Group LLC.’s holdings in UnitedHealth Group were worth $2,691,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in UNH. AMF Tjanstepension AB grew its stake in UnitedHealth Group by 88.0% in the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after purchasing an additional 121,180 shares in the last quarter. Czech National Bank grew its stake in shares of UnitedHealth Group by 7.3% in the third quarter. Czech National Bank now owns 188,110 shares of the healthcare conglomerate’s stock valued at $109,984,000 after buying an additional 12,721 shares in the last quarter. Hudson Value Partners LLC raised its position in UnitedHealth Group by 8.3% during the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after acquiring an additional 82 shares in the last quarter. Versant Capital Management Inc grew its position in shares of UnitedHealth Group by 17.8% in the 3rd quarter. Versant Capital Management Inc now owns 1,011 shares of the healthcare conglomerate’s stock valued at $591,000 after acquiring an additional 153 shares during the period. Finally, Ignite Planners LLC lifted its stake in UnitedHealth Group by 11.2% in the 3rd quarter. Ignite Planners LLC now owns 1,353 shares of the healthcare conglomerate’s stock valued at $791,000 after purchasing an additional 136 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Bank of America reduced their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. UBS Group reduced their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. TD Cowen boosted their price objective on UnitedHealth Group from $601.00 to $609.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a report on Tuesday, December 3rd. One research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Down 0.6 %

Shares of UNH opened at $545.08 on Wednesday. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $630.73. The firm has a 50 day simple moving average of $535.03 and a two-hundred day simple moving average of $565.09. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The company has a market cap of $501.63 billion, a P/E ratio of 35.17, a P/E/G ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the previous year, the business posted $5.83 earnings per share. The business’s revenue for the quarter was up 6.8% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.